NEW YORK (GenomeWeb) – Genome analysis company Genomics plc said today that it has closed a £25 million ($32.5 million) Series B funding round.

Vertex Pharmaceuticals led the round with a £10.5 million equity investment as part of a new, multiyear R&D partnership with Genomics. The IP Group, Woodford Investment Management, Invesco Perpetual, Oxford Sciences Innovation, Lansdowne Partners, and Tanarra also participated in the Series B.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.